Skip to main content
. 2020 May 11;133(12):1448–1455. doi: 10.1097/CM9.0000000000000836

Figure 3.

Figure 3

11C-CFT PET and 18F-FDG PET imaging of patients with CBD. (A) patients with CBD have an obvious asymmetric decrease in DAT intake (white arrows); (B) the metabolism of FDG in the left cerebral hemisphere of patients with CBD decreases (white arrow), but no obvious abnormality is observed on the right side, which is asymmetric. 11C-CFT: 2β-carbomethoxy-3β-(4-fluorophenyl)-[N-11C-methyl]tropane; CBD: Corticobasal degeneration; DAT: Dopamine transporter; 18F-FDG: 18F-fluorodeoxyglucose; PET: Positron emission computed tomography.